Ads
related to: Acute Myeloid Leukemia- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Dosing & Monitoring
Search results
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 2 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 hour agoMP0533: Phase 1 trial continues to demonstrate acceptable safety and antitumor activity up to cohort 6, dosing in cohort 7 ongoing, additional dose escalation cohorts being preparedRadio-DARPin Therapy (RDT): Lead DLL3 candidate advancing into
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoTurning now to the progress we have made with our lead product candidate, prexigebersen. As you know, last year, we reported positive interim results from Stage 2 of our Phase 2 clinical trial ...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 1 day agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
Actinium Announces Multiple Abstracts Highlighting its Antibody Radiation Conjugates Iomab-B and...
WJTV Jackson· 3 days agoIomab-B and Actimab-A are the only targeted radiotherapies in development for patients with relapsed/refractory acute myeloid leukemia
$725M Verdict Against ExxonMobil in Landmark Benzene Cancer Case
WKRN Nashville· 1 day agoAndrew DuPont of Locks Law Firm, obtained a verdict of $725.5M against ExxonMobil on behalf of Paul Gill and his wife Diane Gill in a benzene case in the Philadelphia Court of Common Pleas.
Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients...
FOX 4 Kansas City· 2 days agoThe Phase 3 SIERRA trial enrolled 153 patients ages 55 and above with active relapsed or refractory acute myeloid leukemia (r/r AML) ...
Obituary - Steven Michael Kakuska
Fontana Herald News· 6 days agoSteven Michael Kakuska’s battle with acute myeloid leukemia ended on Saturday, March 27, when he passed away at Kaiser Hospital in Fontana ...
Canaccord cuts Aptose Biosciences shares target, expects lead drug approval delay By Investing.com
Investing.com· 10 hours agoOn Thursday, Canaccord Genuity (TSX:CF) adjusted its price target on Aptose Biosciences...
Danbury High runner who was on death bed with cancer graduates from Sacred Heart: 'Very determined'
The News-Times· 6 days agoIn May 2019, 21-year-old Alex Chakar was diagnosed with acute myeloid leukemia and within a few...